Discovery of Novel Human Histamine H4 Receptor Ligands by Large-Scale Structure-Based Virtual Screening

Journal of Medicinal Chemistry
2008.0

Abstract

A structure-based virtual screening (SBVS) was conducted on a ligand-supported homology model of the human histamine H4 receptor (hH4R). More than 8.7 million 3D structures derived from different vendor databases were investigated by docking to the hH4R binding site using FlexX. A total of 255 selected compounds were tested by radioligand binding assay and 16 of them possessed significant [(3)H]histamine displacement. Several novel scaffolds were identified that can be used to develop selective H4 ligands in the future. As far as we know, this is the first SBVS reported on H4R, representing one of the largest virtual screens validated by the biological evaluation of the virtual hits.

Knowledge Graph

Similar Paper

Discovery of Novel Human Histamine H4 Receptor Ligands by Large-Scale Structure-Based Virtual Screening
Journal of Medicinal Chemistry 2008.0
Structure-based virtual screening for fragment-like ligands of the G protein-coupled histamine H<sub>4</sub>receptor
MedChemComm 2015.0
2,4-Diaminopyrimidines as histamine H4 receptor ligands—Scaffold optimization and pharmacological characterization
Bioorganic &amp; Medicinal Chemistry 2009.0
Synthesis and evaluation of a 2-benzothiazolylphenylmethyl ether class of histamine H4 receptor antagonists
Bioorganic &amp; Medicinal Chemistry Letters 2016.0
Histamine H4 receptor agonists
Bioorganic &amp; Medicinal Chemistry Letters 2010.0
Molecular Determinants of Ligand Binding Modes in the Histamine H<sub>4</sub>Receptor: Linking Ligand-Based Three-Dimensional Quantitative Structure–Activity Relationship (3D-QSAR) Models to in Silico Guided Receptor Mutagenesis Studies
Journal of Medicinal Chemistry 2011.0
Fragment Based Design of New H<sub>4</sub>Receptor−Ligands with Anti-inflammatory Properties in Vivo
Journal of Medicinal Chemistry 2008.0
Ligand based design of novel histamine H4 receptor antagonists; fragment optimization and analysis of binding kinetics
Bioorganic &amp; Medicinal Chemistry Letters 2012.0
Discovery of Quinazolines as Histamine H<sub>4</sub>Receptor Inverse Agonists Using a Scaffold Hopping Approach
Journal of Medicinal Chemistry 2008.0
Mapping histamine H<sub>4</sub>receptor–ligand binding modes
MedChemComm 2012.0